Highlights Genscript Biotech Corporation

Equities

1548

KYG3825B1059

Delayed Hong Kong S.E. Other stock markets 03:04:06 2024-06-03 am EDT			5-day change	1st Jan Change
8.16 ^HKD	-18.40%		-21.69%	-58.91%

09:01am	GenScript Biotech Draws Attention from US Congress Members; Shares Tank 18%	MT
08:15am	GenScript Biotech Shares Drop After U.S. Lawmakers Scrutinize Chinese Ties	DJ

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Legend Expects to Log Profit in 2026	May. 15	MT
Legend Biotech's Loss Narrows in Q1 as Revenue Surges	May. 14	MT
GenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic Applications	May. 13	CI
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing	Apr. 23	CI
Genscript Biotech's Unit Logs $157 Million in Q1 Sales of Blood Cancer Drug	Apr. 17	MT
Genscript Biotech's 2023 Loss Widens; Misses Revenue Estimates	Mar. 10	MT
Genscript Biotech Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 10	CI
GenScript Biotech Corporation Expands Collaboration with Roche	Mar. 05	CI
Genscript Biotech Unit Secures US FDA Nod for Carvykti Label Update	Dec. 21	MT
Genscript Biotech's Controlling Shareholder Sells 0.4% Stake to Hillhouse Unit	Dec. 20	MT
Genscript Subsidiary Legend Biotech Grants Novartis License to Develop Anti-Cancer Drug	Nov. 13	MT
GenScript Biotech Corporation Expands its IVT mRNA Synthesis Portfolio with Addition of Customized Circular RNA and Lipid Nanoparticles Formulation Services	23-09-18	CI
Genscript Biotech Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-20	CI
Genscript Biotech's Q2 Attributable Loss Widens; Shares Fall 3%	23-08-16	MT
GenScript Biotech Corporation Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs	23-08-08	CI
GenScript Biotech's Non-Cell Therapy Business Revenues Seen to Increase in First Half; Shares Drop 7%	23-07-14	MT
Genscript Biotech Corporation Doubles cGMP sgRNA and Non-Viral DNA Payload Manufacturing Capacity	23-07-06	CI
Genscript Bio Unit Completes Sale of Stake for Capital Injection	23-06-26	MT
Genscript Biotech Corporation Debuts Ammag Quatro to Revolutionize Automated Plasmid Maxi- Prep Purification	23-06-20	CI
Genscript Bio Unit Legend Biotech Applies for Expanded Use of Myeloma Medication in Europe; Shares Fall 4%	23-05-29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Genscript Biotech Corporation

Equities

1548

KYG3825B1059

Highlights

Filters